Bausch Health Companies (TSE:BHC) Shares Up 3% – Should You Buy?

Bausch Health Companies Inc. (TSE:BHC) shot up 3% during mid-day trading on Thursday . The company traded as high as C$11.67 and last traded at C$11.61. 76,142 shares traded hands during mid-day trading, a decline of 44% from the average session volume of 137,096 shares. The stock had previously closed at C$11.27.

Wall Street Analyst Weigh In

Separately, Evercore ISI upgraded Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th.

Bausch Health Companies Price Performance

The firm has a fifty day moving average of C$11.63 and a two-hundred day moving average of C$10.18. The stock has a market capitalization of C$4.26 billion, a P/E ratio of -6.63, a P/E/G ratio of 0.21 and a beta of 0.77. The company has a debt-to-equity ratio of 7,583.76, a current ratio of 1.19 and a quick ratio of 0.58.

Bausch Health Companies (TSE:BHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported C$1.53 EPS for the quarter, beating the consensus estimate of C$1.43 by C$0.10. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. The business had revenue of C$3.42 billion during the quarter, compared to analyst estimates of C$3.36 billion. On average, analysts predict that Bausch Health Companies Inc. will post 5.5472637 EPS for the current year.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.